Scioscia, G.; Tondo, P.; Nolasco, S.; Pelaia, C.; Carpagnano, G.E.; Caiaffa, M.F.; Valenti, G.; Maglio, A.; Papia, F.; Triggiani, M.;
et al. Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. J. Clin. Med. 2023, 12, 4362.
https://doi.org/10.3390/jcm12134362
AMA Style
Scioscia G, Tondo P, Nolasco S, Pelaia C, Carpagnano GE, Caiaffa MF, Valenti G, Maglio A, Papia F, Triggiani M,
et al. Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of Clinical Medicine. 2023; 12(13):4362.
https://doi.org/10.3390/jcm12134362
Chicago/Turabian Style
Scioscia, Giulia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Maria Filomena Caiaffa, Giuseppe Valenti, Angelantonio Maglio, Francesco Papia, Massimo Triggiani,
and et al. 2023. "Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience" Journal of Clinical Medicine 12, no. 13: 4362.
https://doi.org/10.3390/jcm12134362
APA Style
Scioscia, G., Tondo, P., Nolasco, S., Pelaia, C., Carpagnano, G. E., Caiaffa, M. F., Valenti, G., Maglio, A., Papia, F., Triggiani, M., Crimi, N., Pelaia, G., Vatrella, A., Foschino Barbaro, M. P., & Crimi, C.
(2023). Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of Clinical Medicine, 12(13), 4362.
https://doi.org/10.3390/jcm12134362
